Logo image of ASTR

ASTRA SPACE INC (ASTR) Stock Fundamental Analysis

NASDAQ:ASTR - Nasdaq - US04634X2027 - Common Stock - Currency: USD

0.539  -0.01 (-2%)

After market: 0.53 -0.01 (-1.67%)

Fundamental Rating

1

ASTR gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 64 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of ASTR have multiple concerns. ASTR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ASTR has reported negative net income.
In the past year ASTR has reported a negative cash flow from operations.
ASTR had negative earnings in each of the past 5 years.
ASTR had a negative operating cash flow in each of the past 5 years.
ASTR Yearly Net Income VS EBIT VS OCF VS FCFASTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -200M -400M -600M -800M -1B

1.2 Ratios

The Return On Assets of ASTR (-121.99%) is worse than 90.91% of its industry peers.
Industry RankSector Rank
ROA -121.99%
ROE N/A
ROIC N/A
ROA(3y)-240.11%
ROA(5y)-210.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ASTR Yearly ROA, ROE, ROICASTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 500 -500

1.3 Margins

Looking at the Gross Margin, with a value of 53.34%, ASTR belongs to the top of the industry, outperforming 89.39% of the companies in the same industry.
ASTR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ASTR Yearly Profit, Operating, Gross MarginsASTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -1K -2K -3K -4K

0

2. Health

2.1 Basic Checks

ASTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ASTR has been reduced compared to 1 year ago.
Compared to 1 year ago, ASTR has a worse debt to assets ratio.
ASTR Yearly Shares OutstandingASTR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 20M 40M 60M
ASTR Yearly Total Debt VS Total AssetsASTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

ASTR has an Altman-Z score of -39.96. This is a bad value and indicates that ASTR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ASTR (-39.96) is worse than 92.42% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -39.96
ROIC/WACCN/A
WACC5.76%
ASTR Yearly LT Debt VS Equity VS FCFASTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 0.41 indicates that ASTR may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.41, ASTR is doing worse than 95.45% of the companies in the same industry.
A Quick Ratio of 0.21 indicates that ASTR may have some problems paying its short term obligations.
ASTR's Quick ratio of 0.21 is on the low side compared to the rest of the industry. ASTR is outperformed by 96.97% of its industry peers.
Industry RankSector Rank
Current Ratio 0.41
Quick Ratio 0.21
ASTR Yearly Current Assets VS Current LiabilitesASTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M

4

3. Growth

3.1 Past

ASTR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.07%, which is quite impressive.
Looking at the last year, ASTR shows a very negative growth in Revenue. The Revenue has decreased by -23.77% in the last year.
EPS 1Y (TTM)73.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%130.99%
Revenue 1Y (TTM)-23.77%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 32.48% on average over the next years. This is a very strong growth
Based on estimates for the next years, ASTR will show a very strong growth in Revenue. The Revenue will grow by 82.86% on average per year.
EPS Next Y48.98%
EPS Next 2Y32.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year97.77%
Revenue Next 2Y82.86%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

ASTR Yearly Revenue VS EstimatesASTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 20M 40M 60M
ASTR Yearly EPS VS EstimatesASTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -5 -10 -15

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ASTR. In the last year negative earnings were reported.
Also next year ASTR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASTR Price Earnings VS Forward Price EarningsASTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ASTR Per share dataASTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4 -5

4.3 Compensation for Growth

A more expensive valuation may be justified as ASTR's earnings are expected to grow with 32.48% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.48%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ASTR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ASTRA SPACE INC

NASDAQ:ASTR (7/17/2024, 8:00:00 PM)

After market: 0.53 -0.01 (-1.67%)

0.539

-0.01 (-2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)05-23 2024-05-23/amc
Earnings (Next)08-08 2024-08-08
Inst Owners0.95%
Inst Owner Change-100%
Ins Owners174.02%
Ins Owner Change0%
Market Cap12.34M
Analysts43.33
Price Target15.3 (2738.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.96
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.61
EYN/A
EPS(NY)-1.84
Fwd EYN/A
FCF(TTM)-3.66
FCFYN/A
OCF(TTM)-3.49
OCFYN/A
SpS0.18
BVpS-1.47
TBVpS-1.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -121.99%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.34%
FCFM N/A
ROA(3y)-240.11%
ROA(5y)-210.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 58.52%
Cap/Sales 93.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.41
Quick Ratio 0.21
Altman-Z -39.96
F-Score5
WACC5.76%
ROIC/WACCN/A
Cap/Depr(3y)428.83%
Cap/Depr(5y)322.39%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%130.99%
EPS Next Y48.98%
EPS Next 2Y32.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-23.77%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year97.77%
Revenue Next 2Y82.86%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y59.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year41.3%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y59.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y46.38%
OCF growth 3YN/A
OCF growth 5YN/A